| Articles Reviewed |
| 1: | Michiyo Sasajima et al. trans-3,4'-Dimethyl-3-hydroxyflavanone, a hair growth enhancing active component, decreases active transforming growth factor beta2 (TGF-beta2) through control of urokinase-type plasminogen activator (uPA) on the surface of keratinocytes. 2008 |
| 2: | Jeong-Seok Nam et al. Bone sialoprotein mediates the tumor cell-targeted prometastatic activity of transforming growth factor beta in a mouse model of breast cancer. 2006 |
| 3: | Kengo Furuichi et al. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury. 2006 |
| 4: | York Hunt Ng et al. Differential effects of interleukin-1beta and transforming growth factor-beta1 on the expression of the inflammation-associated protein, ADAMTS-1, in human decidual stromal cells in vitro. 2006 |
| 5: | Mehrnaz Gharaee-Kermani et al. Gender-based differences in bleomycin-induced pulmonary fibrosis. 2005 |
| 6: | Elangovan Vellaichamy et al. Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. 2005 |
| 7: | S Toyran et al. Expression of growth differentiation factor-5 and bone morphogenic protein-7 in intraocular osseous metaplasia. 2005 |
| 8: | Eun Ok Lee et al. The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. 2005 |
| 9: | Ju-Eun Oh et al. Beta ig-h3 induces keratinocyte differentiation via modulation of involucrin and transglutaminase expression through the integrin alpha3beta1 and the phosphatidylinositol 3-kinase/Akt signaling pathway. 2005 |
| 10: | Yoshihide Asano et al. Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. 2004 |
| 11: | Qizhi Tang et al. Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function. 2004 |
| 12: | Christian Stoll et al. Analysis of polymorphic TGFB1 codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults. 2004 |
| 13: | Francesco Cipollone et al. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 2004 |
| 14: | Jin H Li et al. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. 2004 |
| 15: | Medhat Shehata et al. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. 2004 |
| 16: | Mario Schiffer et al. A novel role for the adaptor molecule CD2-associated protein in transforming growth factor-beta-induced apoptosis. 2004 |
| 17: | Zenzo Isogai et al. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. 2003 |
| 18: | Julia I Leu et al. Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice. 2003 |
| 19: | Mohammed S Razzaque et al. Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid. 2003 |
| 20: | Immaculada Herrero-Fresneda et al. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy?. 2003 |
| 21: | Katrien Janssens et al. Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. 2003 |
| 22: | Megan K Levings et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. 2002 |
| 23: | Dimitrios S Goumenos et al. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. 2002 |
| 24: | Susan Fanayan et al. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. 2002 |
| 25: | Elizabeth Gore-Hyer et al. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. 2002 |
| 26: | F Cavallo et al. Interleukin 12-activated lymphocytes influence tumor genetic programs. 2001 |